Reactions Weekly

, Volume 1633, Issue 1, pp 63–63 | Cite as

Antineoplastics

Pneumocystis jirovecii pneumonia: 5 case reports
Case report
  • 46 Downloads

Reference

  1. Hardak E, et al. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/ sulfamethoxazole: A single-center experience. Acta Haematologica 127: 110-114, No. 2, Feb 2012. Available from: URL: http://doi.org/10.1159/000334113 - Israel

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations